Figure 2.
Figure 2. VWF multimer analysis of type 2B VWD cases. VWF multimer analysis (1% agarose gel) demonstrates the characteristic deficiency of high-molecular-weight multimers in 2 of the cases described with type 2B VWD. In each set of gel images, the patient plasma is compared with a normal plasma control (N). (A) The patient in case 1 (P) has loss of high- and some intermediate-weight VWF multimers. Affected multimer sizes are indicated by the bracket. (B) The patient in case 3 shows persistent deficiency of large- and some intermediate-weight VWF multimers on this VWF:Ag normalized multimer gel comparing a sample from her baseline (from an archival plasma sample) with samples during gestation (indicated in weeks [wks]).

VWF multimer analysis of type 2B VWD cases. VWF multimer analysis (1% agarose gel) demonstrates the characteristic deficiency of high-molecular-weight multimers in 2 of the cases described with type 2B VWD. In each set of gel images, the patient plasma is compared with a normal plasma control (N). (A) The patient in case 1 (P) has loss of high- and some intermediate-weight VWF multimers. Affected multimer sizes are indicated by the bracket. (B) The patient in case 3 shows persistent deficiency of large- and some intermediate-weight VWF multimers on this VWF:Ag normalized multimer gel comparing a sample from her baseline (from an archival plasma sample) with samples during gestation (indicated in weeks [wks]).

Close Modal

or Create an Account

Close Modal
Close Modal